Better Therapeutics, Inc. (BTTX) Financials

BTTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 10.7 million 20.7 million
2023-06-30 11.6 million 22.4 million
2023-03-31 12.8 million 22.6 million
2022-12-31 22.9 million 23.8 million

BTTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.9 million 427000
2023-06-30 -5.6 million 478000
2023-03-31 -9.2 million 410000
2022-12-31 -6.7 million 449000

BTTX Net Income

No data available :(

BTTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 6.6 million - -
2023-06-30 6.2 million - -
2023-03-31 6.1 million - -
2022-12-31 15.7 million - -

BTTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 38.5 million
2023-06-30 31.2 million
2023-03-31 23.8 million
2022-12-31 23.7 million

BTTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 5000 1.8 million 2.1 million 1.4 million
2023-06-30 503000 2.2 million 3.1 million 1.7 million
2023-03-31 521000 3.4 million 3.4 million 2.1 million
2022-12-31 360000 3.0 million 3.6 million 1.7 million

BTTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 841000
2023-06-30 - 797000
2023-03-31 - 755000
2022-12-31 - 721000

BTTX

Price: $0.01

52 week price:
0.01
1.35

Earnings Per Share: -1.10 USD

P/E Ratio: -0.14

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 41300

Market Capitalization: 545156

Links: